Catamount Wealth Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Catamount Wealth Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-200	Closed	-$3K	–	193
2018 Q2	$3K	Sell	200 -100	-33%	-$1.35K	﹤0.01%	174
2018 Q1	$4K	Sell	300 -200	-40%	-$2.43K	﹤0.01%	166
2017 Q4	$7K	Hold	500	–	–	﹤0.01%	150
2017 Q3	$8K	Hold	500	–	–	﹤0.01%	143
2017 Q2	$8K	Buy	+500	New	+$7.47K	﹤0.01%	138

Other funds holding OXFD

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Catamount Wealth Management's OXFD Position: Q3 2018 in Review

Catamount Wealth Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2018, closing a stake of 200 shares — an estimated $3K sold.

Catamount Wealth Management first reported a position in OXFD in Q2 2017 and held it in 5 quarters. The position peaked at $8K in Q3 2017. 83 funds tracked by Wall St. Rank hold OXFD as of Q3 2018.

Catamount Wealth Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2018 after selling out during the quarter.
Catamount Wealth Management sold 200 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2018, an estimated $3K.
Catamount Wealth Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2017 and held it in 5 quarters.
Catamount Wealth Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $8K in Q3 2017.
83 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2018.

Based on Catamount Wealth Management's 13F filing for Q3 2018, filed 13 Nov 2018.